SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-22-022934
Filing Date
2022-09-23
Accepted
2022-09-22 18:49:08
Documents
14
Period of Report
2022-06-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A cbli20220922_8ka.htm   iXBRL 8-K/A 33044
2 EXHIBIT 99.1 ex_426023.htm EX-99.1 6982
  Complete submission text file 0001437749-22-022934.txt   179758

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA stab-20220613.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220613_def.xml EX-101.DEF 11904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220613_lab.xml EX-101.LAB 15929
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220613_pre.xml EX-101.PRE 12115
8 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220922_8ka_htm.xml XML 2709
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-32954 | Film No.: 221260316
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences